NASDAQ$ADUS

Addus HomeCare Corporation · Q3 2021 earnings

Q3 2021 earnings · · Investor relations

Briefing

Addus HomeCare reported an increase in revenue and net income for Q3 2021.

Addus HomeCare Corporation announced its financial results for the third quarter ended September 30, 2021, with net service revenues increasing by 11.7% to $216.7 million and net income increasing by 27.0% to $11.6 million, or $0.72 per diluted share. Adjusted net income per diluted share was $0.91, and adjusted EBITDA increased by 27.4% to $24.9 million.

  • Net service revenues increased 11.7% to $216.7 million compared to Q3 2020.
  • Net income increased 27.0% to $11.6 million compared to Q3 2020.
  • Adjusted net income per diluted share increased 19.7% to $0.91.
  • Adjusted EBITDA increased 27.4% to $24.9 million.

Headline financials

Total Revenue

$217M

Previous: $194M+11.7%
EPS (adj)

$0.91

Previous: $0.76+19.7%
Capital Expenditures

-$3.21M

Previous: -$5.89M+45.5%
Free Cash Flow

$8.36M

Previous: $3.23M+159.2%
Net Income

$11.6M

Previous: $9.12M+27.0%
Operating Income

$17.4M

Previous: $12.5M+38.6%
Gross Profit

$67M

Previous: $56.3M+19.1%
Cash & Equivalents

$152M

Previous: $170M-10.5%
Total Assets

$925M

Previous: $695M+33.0%
Stock-Based Comp

$2.34M

Previous: $1.46M+60.1%

Revenue & EPS history

Addus · Revenue · Quarterly

$217M

Q3 2021+11.7%vs Q3 2020
Beat estimate in 12 of 16 quarters(75%)
ActualEstimate

Revenue by segment

Addus · $217M total across 3 segments · Q3 2021

  • Personal Care
    $170M+2.2%
  • Hospice
    $39.1M+63.0%
  • Home Health
    $7.96M+94.8%

Forward guidance

The company continues to benefit from a favorable environment for home-based care with strong demand trends and increased government recognition and support through state and federal funding.

Tailwinds

  • Favorable environment for home-based care.
  • Strong demand trends in the home care sector.
  • Increased government recognition and support through state and federal funding.
  • Addus is well positioned to meet the demand across its operating segments.
  • Proven operating model and a dedicated team of frontline caregivers and support staff.

Headwinds

  • Pressures related to the surge in the Delta variant of COVID-19.
  • Tightening labor market.
  • Potential effect on growth in certain markets due to labor market and COVID-19.
  • Uncertainty regarding the outcome of discussions with managed care organizations.
  • Impact to business operations, reimbursements and patient population due to the recent COVID-19 global pandemic

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2021

Historical avgQ3 2021

+1.2%

Avg return

Earnings day

+2.3%

Avg return

5 days after

+5.0%

Avg return

30 days after

58%

37 / 64 earnings

Positive

+23.7%

Q4 2019

Best reaction

-19.6%

Q4 2013

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-1.7%-0.6%-10.6%
Q4 2025-9.1%-12.0%-17.0%
Q3 2025-5.9%-5.0%-4.1%
Q1 2025+4.1%+6.3%+7.5%
Q4 2024-10.4%-12.0%-10.1%
Q3 2024-1.7%+1.0%-2.1%
Q2 2024+3.5%+3.6%+8.5%
Q1 2024+6.5%+11.3%+16.8%
Q4 2023+3.4%+5.3%+16.4%
Q3 2023-3.7%+3.3%+7.0%
Q2 2023+1.2%+3.9%-0.1%
Q1 2023+5.8%+0.3%+10.3%
Q4 2022+3.9%+2.5%-0.4%
Q3 2022+3.1%+3.8%+4.8%
Q2 2022+3.1%+0.6%-3.9%
Q1 2022-2.3%-4.7%-4.2%
Q4 2021+20.5%+20.4%+15.8%
Q3 2021-0.5%+9.1%-8.9%
Q2 2021+9.1%+5.3%+4.0%
Q1 2021-6.6%-8.1%-10.0%
Q4 2020-11.3%-14.2%-11.3%
Q3 2020+11.9%+10.3%+4.6%
Q2 2020+2.7%-4.6%-7.1%
Q1 2020+10.2%+2.7%+22.5%
Q4 2019+23.7%+8.5%+42.1%
Q3 2019-0.9%-0.1%+8.6%
Q2 2019+1.4%+4.4%-0.2%
Q1 2019+3.6%+3.0%+8.8%
Q4 2018-2.8%-7.8%-3.8%
Q3 2018+6.5%+10.8%+16.7%
Q2 2018-4.4%-7.1%-3.4%
Q1 2018+3.1%+1.8%+11.9%
Q4 2017-0.3%+8.6%+38.5%
Q3 2017-1.4%-5.8%-7.8%
Q2 2017-0.3%-1.4%-1.3%
Q1 2017+11.3%+9.4%+2.6%
Q4 2016+1.2%+0.1%-7.5%
Q3 2016+17.4%+28.7%+32.7%
Q2 2016+13.8%+8.6%+27.1%
Q1 2016-1.1%
Q4 2015-16.6%
Q3 2015-12.7%
Q2 2015+4.4%
Q1 2015-3.4%
Q4 2014+3.7%
Q3 2014+7.1%
Q2 2014+1.3%
Q1 2014+1.8%
Q4 2013-19.6%
Q3 2013+4.3%
Q2 2013+9.3%
Q1 2013+0.9%
Q4 2012+13.2%
Q3 2012+10.5%
Q2 2012+1.1%
Q1 2011-0.0%
Q1 2012-7.8%
Q4 2011+6.6%
Q3 2010-1.3%
Q3 2011-1.3%
Q2 2011-17.3%
Q2 2010-17.3%
Q4 2010+0.2%
Q1 2010+2.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro